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Neurons can fire at extremely high rates. To sustain neurotransmission, synap-
tic vesicles must be recycled locally at synapses. Two models for synaptic
vesicle endocytosis have been put forward based on the morphological studies
in frog neuromuscular junctions. Heuser and Reese proposed that endocytosis
occurs via a slow mechanism using clathrin scaffolds. Ceccarelli and his co-
workers proposed a fast mechanism, kiss-and-run. Since then, many studies
have sought to identify the mechanism for synaptic vesicle endocytosis. How-
ever, instead of resolving the issue, conflicting evidence has accumulated over
the years. The molecular studies have suggested clathrin and clathrin-
associated proteins are essential. However, the kinetics studies have suggested
that both forms co-exist. Our data identify a third pathway that is fast, but re-
quires clathrin to regenerate vesicles.
To investigate how endocytosis takes place, we developed a method, ‘flash-
and-freeze’ fixation that couples optogenetic stimulation with rapid high-
pressure freezing and captures endocytosis at millisecond temporal resolution.
To our surprise, vesicle membrane is recovered via ultrafast endocytosis within
100 ms following a single stimulus. The large endocytic vesicles then fuse to
form an endosome and are resolved by clathrin into synaptic vesicles in 5-6
s. When experiments are performed at 20C instead of 37C, ultrafast endocy-
tosis fails, and clathrin regenerates synaptic vesicles directly from plasma
membrane. These results suggest that recycling of synaptic vesicles is normally
a rapid two-step process: ultrafast endocytosis that removes excess membrane
from the surface and then clathrin-mediated biogenesis of synaptic vesicles
from endosomes.
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Synapses continually replenish their synaptic vesicle (SV) pools while sup-
pressing spontaneous fusion events, thus maintaining a high dynamic range
in response to physiological stimuli. The presynaptic protein complexin
(CPX) inhibits fusion through interactions between its highly conserved central
helix and the SNARE complex. Two poorly conserved domains (the accessory
helix and the C-terminal domain) on either side of the central helix (CH) are
also required for inhibition of spontaneous fusion. We found that the C-termi-
nal domain (CTD) binds lipids through a novel protein motif, permitting com-
plexin to inhibit spontaneous exocytosis in vivo by targeting complexin to
highly curved membranes such as SVs. Membrane curvature enhanced CPX
binding and induced conformational changes in a critical amphipathic region
of the CTD. The accessory helix (AH) of CPX contributes to the inhibition
of exocytosis but the molecular mechanism for this function remains unknown.
Several models have been proposed for the role of AH based on the concept thatAH competes with VAMP for a binding site on the SNARE complex. Using a
series of AH mutations and chimeras with mouse AH together with NMR and
CD spectroscopy, electrophysiology, and behavioral assays, we identified key
features of the AH and CH required for inhibition of SV fusion by CPX. We
propose that the AH stabilizes the CH through nucleation and propagation of
helical secondary structure, thereby facilitating binding of the CH to the
SNARE complex.
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Despite the immense progress in identifying the essential molecules in the
exocytotic pathway and the award of the 2013 Nobel Prize in Physiology
and Medicine to colleagues in the field, gaps continue to exist in our under-
standing of the most fundamental aspects of the process. The intent of the
talk is to highlight some of the known unknowns and present recent (surprising)
results concerning the regulation of the fusion pore by the very proteins that are
being discharged upon fusion.
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The initiation of the action potential in excitable cells results from the opening
of voltage-gated sodium channels. In humans, mutations in sodium channels
produce a wide range of neurological and cardiovascular diseases; hence these
channels represent key targets for development of pharmaceutical drugs. So-
dium channel blockers such as lamotrigine and lidocaine have been shown to
have efficacy, respectively, as anti-epileptic and local anaethetic drugs. Sodium
channels are also present in some prokaryotes. We have determined the crystal
structure of one of these, the open pore form of NavMs, the orthologue from
Magnetococcus marinus.
In collaboration with the Clapham group, we have recently shown that drugs
which are known to block eukaryotic sodium channels also bind to and block
the NavMs channel.Crystallographic, computational and electrophysiology
methods have been used to determine the functional effects and locations of
these and related blocker compounds within the channel cavity. One end is
located near the side fenestrations, consistenr with a role for these features in
the entry pathway for drugs into the internal cavity of the pore. The other
end appears to protrude into the selectivity filter, blocking the passage of so-
dium ions into the cavity, and ultimately preventing their exit through the intra-
cellular gate. The binding sites identified have been validated by both structure
and function studies on designed mutants. We have further shown that the af-
finities of all the drugs and analogues tested are remarkably similar for the
NavMs and human Nav1.1 channels, information which should be valuable
for the design of specific and selective drugs.
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